We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nutrients Stop Cancer Metastasis

By Biotechdaily staff writers
Posted on 09 Nov 2005
Cancer metastasis can be stopped in mice by using a combination of nutrients, according to a study presented at the annual combined meeting of the World Congress on Advances in Oncology and the International Symposium on Molecular Medicine, held in Crete (Greece) in October 2005.

The study documents that vitamin C used in combination with the amino acids L-lysine, L-proline, and a polyphenol fraction of green tea known as Epigallocatechin Gallate (EGCG) not only killed cancer cells and significantly limited tumor growth and its infiltration by blood vessels, but also completely stopped the invasion and spread of more than two dozen cancer cell types. More...
The study was conducted by Dr. Rath and colleagues of the Dr. Rath Research Institute (Santa Clara, CA, USA), who note that this marks the first time nutrient synergy has been shown to stop the spread of metastasis in the body of a living organism.

The study results came on the heels of a recent study by the U.S. National Institutes of Health (Bethesda, MD, USA), which strongly confirmed that vitamin C has the potential to fight cancer when injected intravenously in high dosages.

"A growing number of researchers confirm that Dr. Rath was right, and nutrients, especially when used in a synergy, can control all critical stages of cancer,” said Aleksandra Niedzwiecki, Ph.D., director of the institute.

The conference was organized by Demetrios A. Spandidos, professor of virology at the Medical School, University of Crete, who personally invited the Dr. Rath Research Institute team to the event. The institute is calling for a radical change in the therapeutic approach to cancer, one that takes advantage of new natural approaches.





Related Links:
Dr. Rath Research Institute

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.